abstract |
FIELD: medicine.SUBSTANCE: group of inventions refers to medicine, namely to ophthalmology, and aims at treating ophthalmic diseases by subconjunctival injection. Suspension composition for subconjunctival injection into human eye contains cyclosporine A; suspending agent; osmosis-regulating agent; one or more buffers; SAS and carrier. Cyclosporine A has particle size Din range from 70 mcm to 100 mcm. Invention also provides two-component systems for making said suspension for subconjunctival injection and a system for delivering said suspension composition.EFFECT: using the group of inventions enables accelerating resorption in subconjunctival administration.25 cl, 8 dwg, 12 tbl, 9 ex |